| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2025 | Mar 3, 2025 | Whitehawk Therapeutics, Inc. | CEO | Sell | 46.3 | -5,690 | -14.55% | ✗ | $13.4K |
| Oct 2, 2024 | Oct 3, 2024 | Whitehawk Therapeutics, Inc. | CEO | Sell | 46.3 | -9,689 | -29.76% | ✗ | $18.8K |